期刊文献+

长期运动干预改善2型糖尿病肌萎缩的炎症机制研究进展

Research Progress of Inflammatory Mechanism of Long-term Exercise in Improvement of Muscle Atrophy in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 2型糖尿病肌萎缩会引起肌肉功能障碍,严重降低患者日常生活能力和生命质量。血清白细胞介素-6、C反应蛋白和肿瘤坏死因子-α等炎症介质的增加以及肌肉组织中核因子κB和信号转导及转录活化因子3等炎症通路的激活会引起肌细胞的减少或抑制肌细胞的分化,并参与2型糖尿病肌萎缩的发生发展。而长期运动可通过降低肌肉局部或全身炎症,提高骨骼肌质量,进而促进2型糖尿病肌萎缩的康复。但目前长期运动干预改善2型糖尿病肌萎缩的炎症机制仍不清楚。 Muscular atrophy in type 2 diabetes mellitus can cause muscle dysfunction,which will severely reduce the patient′s ability of daily living and quality of life.The elevated serum levels of inflammatory factors such as interleukin-6,C-reactive protein and tumor necrosis factor-α,as well as activation of inflammatory pathways like nuclear factorκB and signal transducer and activator of transcription 3 in muscle tissue,are involved in the occurrence and development of type 2 diabetic muscle atrophy by reducing muscle cell or inhibiting muscle cell differentiation.Long-term exercise can improve musculoskeletal muscle mass and promote the recovery of muscle atrophy in the patients with type 2 diabetes by reducing local muscle inflammation or systemic inflammation.However,the inflammatory mechanism of long-term exercise intervention to improve type 2 diabetic muscle atrophy is still unclear.
作者 黄楚鑫 张力 杨叶虹 HUANG Chuxin;ZHANGT Li;YANG Yehong(Department of Endocrinology,Huashan Hospital,Fudan University,Shanghai 200040,China)
出处 《医学综述》 CAS 2022年第12期2465-2470,共6页 Medical Recapitulate
基金 国家自然科学基金(81970711)。
关键词 2型糖尿病 肌萎缩 运动 炎症机制 Type 2 diabetes Muscle atrophy Exercise Inflammatory mechanism
  • 相关文献

参考文献2

二级参考文献167

  • 1Grandis JR, Drenning SD, Chakraborty A, et al. Requirement of Stat3 but not Statl activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest 1998, 102:1385 - 1392.
  • 2Grandis JR, Drenning SD, Zeng Q, et al. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcino-genesis in vivo. Proc Natl Acad Sci USA 2000, 97:4227-4232.
  • 3Becker S, Groner B, Muller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998,394:145- 151.
  • 4Gray M J, Zhang J, Ellis LM, et al. HIF- 1 alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005, 24:3110- 3120.
  • 5Loeffler S, Fayard B, Weis J, Weissenberger J. Intedeukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Spl. IntJ Cancer 2005,115:202-213.
  • 6Albanell J, Rojo F, Baselga J. Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839. Semin Oncol 2001, 28:56-66.
  • 7Han SW, Hwang PG, Chung DH, et al. Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD 1839) in chemotherapy-resistant non-small cell lung cancer. Int J Cancer 2005,113:109-115.
  • 8Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA, Group ECO. Phase III randomized trial ofcisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 2005, 23:8646-8654.
  • 9Burtness B. The role of cetuximab in the treatment of squamous cell cancer of the head and neck. Expert Opin Biol Ther 2005, 5:1085-1093.
  • 10Vincent PW, Bridges A J, Dykes D J, et al. Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts. Cancer ChemotherPharmacol 2000, 45:231-238.

共引文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部